Stock listing

NASDAQ:GBIO Generation Bio Co Stock

Follow Generation Bio Co into a list and get an email when it puts out news.

Last close · NASDAQ:GBIO

$5.34 USD

Close on Feb 6, 2026 · No longer trades

Jul 22, 2025 to last close +25.1% · daily closes, Jul 22, 2025 – Feb 6, 2026
Lowest – highest close
$4.04 – $6.71 USDSince Jul 22, 2025 · lowest Aug 11, 2025 · highest Oct 15, 2025

Delisted NASDAQ:GBIO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:GBIO
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Generation Bio Co on 6ix

Decks
4 decks · latest Sep 26, 2024

Decks

DeckKindSlidesDate
BPI East 2024Conference21 slidesSep 26, 2024
ESGCT 30th Annual Congress (October 2023)Conference23 slidesOct 26, 2023
Technical Presentation (October 2023)Technical4 slidesOct 26, 2023
OTS Webinar October 2023Conference36 slidesOct 12, 2023

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Charles A Rowland Jr
Other companies: Viking Therapeutics, Inc. (Director · Since at least Jul 1, 2017); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Aug 3, 2022 · Past); Blueprint Medicines Corp (Director · Apr 30, 2015 – Jun 2, 2021 · Past); Vitae Pharmaceuticals Inc (Director · Sep 24, 2014 – Oct 25, 2016 · Past); BIND Therapeutics Inc (Director · May 28, 2014 – Jun 21, 2016 · Past); Idenix Pharmaceuticals Inc (Director · Jun 6, 2013 – Aug 5, 2014 · Past); Viropharma Inc (VP, Chief Financial Officer · Oct 20, 2008 – Jan 24, 2014 · Past)
Director · Since at least Jun 11, 2020
Stephen J DiPalma
Other companies: Inozyme Pharma Inc (Interim CFO · May 17, 2021 – May 17, 2021 · Past); Solid Biosciences Inc. (Interim CFO · Jan 29, 2021 – Jan 29, 2021 · Past); Chemomab Therapeutics Ltd. (Chief Financial Officer · May 1, 2020 – May 1, 2020 · Past); Spero Therapeutics, Inc. (See Remarks · Nov 8, 2019 – Jul 15, 2023 · Past); Interleukin Genetics Inc (Interim CFO · Jul 29, 2016 – Jul 29, 2016 · Past)
See Remarks · Jun 11, 2020 – Jun 11, 2020 · Past
Jason Rhodes
Other companies: Dyne Therapeutics, Inc. (Chairman · Since at least Sep 16, 2020); Disc Medicine, Inc. (Director · Feb 5, 2021 – Oct 4, 2021 · Past); Replimune Group, Inc. (Director · Jul 19, 2018 – Apr 1, 2022 · Past); Epizyme Inc (President, CFO and Treasurer · May 30, 2013 – Sep 22, 2014 · Past)
Director · Since at least Jun 11, 2020
Catherine Stehman-Breen
Other companies: Tenaya Therapeutics, Inc. (Board Member · Since at least Jul 29, 2021); Dyne Therapeutics, Inc. (Board Member · Since at least Jul 31, 2020); Sarepta Therapeutics, Inc. (SVP, Chief Medical Officer · Apr 3, 2017 – Apr 3, 2017 · Past)
Director · Since at least Jun 11, 2020
Jeffrey M Jonas
Other companies: COMPASS Pathways Plc (Director · Since at least Oct 29, 2025); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Mar 15, 2024 · Past); Sage Therapeutics Inc (Director · May 23, 2019 – Jun 10, 2024 · Past)
Director · Since at least Jun 11, 2020
Ron Cooper
Other companies: enGene Therapeutics Inc. (Chief Executive Officer · Since at least Jul 22, 2024); C4 Therapeutics, Inc. (Director · Since at least Jun 7, 2024); Albireo Pharma Inc (President and CEO, Director · Nov 3, 2016 – Mar 2, 2023 · Past)
Director · Since at least Mar 1, 2021
Donald William Nicholson
Other companies: Disc Medicine, Inc. (Director · Since at least Dec 29, 2022); Kymera Therapeutics, Inc. (Director · Jun 16, 2021 – Jun 15, 2022 · Past)
Director · Since at least Jan 11, 2021
Geoff McDonough
Other companies: Third Harmonic Bio Inc. (Director · Mar 27, 2024 – Mar 27, 2024 · Past); Surface Oncology Inc (Director · Jun 5, 2019 – Jun 8, 2021 · Past)
Director · Since at least Jun 11, 2020
Gustav Christensen
Other companies: Morphic Holding Inc (Director · Jun 26, 2019 – Aug 16, 2024 · Past); Dyax Corp (CEO and President, Director · Apr 26, 2007 – Jan 14, 2016 · Past)
Director · Since at least Jun 11, 2020
Douglas Kerr
Other companies: Dyne Therapeutics, Inc. (Head of R&D and CMO · Since at least Sep 3, 2024)
CHIEF MEDICAL OFFICER · Jun 11, 2020 – Jan 29, 2024 · Past
All 19 people
PersonSeat
Matthew Norkunas
Other companies: Obsidian Therapeutics, Inc. (Director · Since at least Aug 3, 2026)
CHIEF FINANCIAL OFFICER · Jan 22, 2021 – Jan 10, 2025 · Past
Yalonda Howze
Other companies: Codiak BioSciences Inc (See Remarks · Jul 2, 2020 – Mar 30, 2023 · Past)
INTERIM CEO AND PRESIDENT · Since at least Apr 5, 2023
Anthony G QuinnDirector · Since at least Jun 4, 2025
Antoinette PaoneCHIEF OPERATING OFFICER · Since at least Feb 10, 2022
Kevin John ConwayCHIEF FINANCIAL OFFICER · Since at least Jan 10, 2025
Mark D AngelinoCHIEF OPERATING OFFICER · Jun 11, 2020 – Feb 5, 2021 · Past
Matthew StantonCHIEF SCIENTIFIC OFFICER · Jun 11, 2020 – Jan 10, 2025 · Past
Phillip SamayoaCHIEF SCIENTIFIC OFFICER · Since at least Sep 16, 2022
Tracy ZimmermannCHIEF DEVELOPMENT OFFICER · Nov 9, 2020 – Jan 29, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about Generation Bio Co.